The medical industry briefing
The latest news, approvals and clinical trials you need to know about this month
News in Numbers
Eye surgeons at the Rabin Medical Center in Israel have successfully implanted the first artificial cornea into a 78-year-old bilaterally blind human patient.
GlobalData forecasts that the gastric bands and balloons market will decline at 5.2% CAGR due to Covid-19.
According to the UK Government, there are approximately 600,000 medical devices available on the UK market.
The estimated revenue loss in the US due to major elective surgery cessation, according to a Annals of Surgery report.
The global market value for orthopedic devices is projected to grow to $64bn by 2025.
Apple warns iPhone 12 owners to keep them away from medical devices
Apple has issued a warning to its customers that the magnets inside the iPhone 12 could interfere with medical devices like pacemakers and defibrillators. The MagSafe technology found within the latest iPhone models enables wireless charging and allows various accessories to be clipped onto the back of the phone.
Source: The Independent
Medical device approvals: FDA takes a STeP in the right direction
The US Food and Drug Administration has released final guidance about its new, voluntary Safer Technologies Program (STeP). Modelled after the Breakthrough Devices Program, STeP is targeted at medical devices and device-led combo products seeking premarket approval, 501(k) premarket notification or a De Novo classification request.
Source: Medical Device Network
A new option for morning-after contraception?
Researchers have found that another type of IUD, one containing the hormone levonorgestrel (Liletta and other brands) works as well as the copper IUD, and perhaps even better than the US FDA-approved oral pills for preventing pregnancy.
Source: The New York Times
Embracing Emerging Technologies
CorNeat Vision develops biomimetic implants that mend and replace damaged tissue for use in the areas of ophthalmology and periodontology.
Source: CorNeat Vision
Dileny Technologies provides intelligent tools for women and health professionals, including radiologists and physicians working in breast health and breast cancer.
Source: Dileny Technologies
UK start-up Arete provides hardware and software for precision, personalised and preventative management of chronic diseases.
US-based company Nines is a tele-radiology and artificial intelligence startup. Its product NinesAI is FDA-cleared to triage time-critical, life-threatening indications of mass effect and intracranial hemorrhage.
Biotechnology company Lucira Health offers disposable at-home test kits to detect infectious diseases, such as Covid-19.
Source: Lucira Health
US-based company Bloomlife is using technology, data science and medical expertise to address issues in maternal health.